Rac GTPases regulate cytoskeletal structure, gene expression, and reactive oxygen species (ROS) production [1, 2]. Rac2-deficient neutrophils cannot chemotax, produce ROS, or degranulate upon G protein-coupled receptor (GPCR) activation [3-10]. Deficiency in PI3K␥, an upstream regulator of Rac, causes a similar phenotype [11-13]. P-Rex1, a guanine-nucleotide exchange factor (GEF) for Rac [14] , is believed to link GPCRs and PI3K␥ to Rac-dependent neutrophil responses. We have investigated the functional importance of P-Rex1 by generating a P-Rex1 −/− mouse. P-Rex1 −/− mice are viable and healthy, with apparently normal leukocyte development, but with mild neutrophilia. In neutrophils from P-Rex1 −/− mice, GPCRdependent Rac2 activation is impaired, whereas Rac1 activation is less compromised. GPCR-dependent ROS formation is absent in lipopolysaccharide (LPS)-primed P-Rex1 −/− neutrophils, but less affected in unprimed or TNF␣-primed cells. Recruitment of P-Rex1 −/− neutrophils to inflammatory sites is impaired. Surprisingly, chemotaxis of isolated neutrophils is only slightly reduced, with a mild defect in cell speed, but normal polarization and directionality. Secretion of azurophil granules is unaffected. In conclusion, P-Rex1 is an important regulator of neutrophil function by mediating a subset of Rac-dependent neutrophil re-*Correspondence: heidi.welch@bbsrc.ac.uk sponses. However, P-Rex1 is not an essential regulator of neutrophil chemotaxis and degranulation.
Generation of P-Rex1
−/− Mice P-Rex1 is the major PtdIns(3,4,5)P 3 -sensitive Rac-GEF in neutrophils and directly activated by Gβγ subunits [14] . To investigate its functional importance, we have generated a P-Rex1 −/− mouse. To delete P-Rex1, we replaced exon 5 with a neomycin resistance cassette and translational stop codon (see Figure S1 in the Supplemental Data available with this article online). Targeting was monitored by Southern blotting ( Figure 1A ). Homozygous P-Rex1 −/− mice were derived by standard protocols into specific-opportunistic pathogen-free isolator conditions and were obtained with the expected Mendelian frequency. The P-Rex1 deletion was confirmed by northern ( Figure 1B ) and western blotting ( Figure 1C ).
Characterization of P-Rex1
−/− Mice P-Rex1 −/− mice were viable, fertile, and apparently healthy, with normal life spans. Ten-week-old P-Rex1 −/− mice weighed on average 14% less than P-Rex1 +/+ mice ( Figure 1D ) and remained smaller throughout adult life (not shown). The livers of P-Rex1 −/− mice were disproportionately smaller than those of P-Rex1 +/+ mice (Figure 1E) .
Peripheral blood leukocyte counts were slightly elevated in P-Rex1 −/− mice, as a result of mild neutrophilia (61% more peripheral P-Rex1 −/− than P-Rex1 +/+ neutrophils), whereas erythrocyte, lymphocyte, monocyte, and platelet numbers were normal ( Figure 1F ). Numbers and maturity of bone-marrow-derived P-Rex1 −/− neutrophils, splenic B and T cells (including marginal zone B cells), and thymocytes (CD4 − /CD8 − , CD4 + /CD8 + , CD4 + /CD8 − , and CD4 − /CD8 + cells) appeared normal ( Figure 1G , and data not shown).
Rac Activation in Neutrophils from P-Rex1
−/− Mice We measured fMLP-stimulated Rac1 and Rac2 activation in purified bone-marrow-derived neutrophils (Figures 2A-2C) . In P-Rex1 +/+ cells, activation was robust and rapid: 2% of Rac1 and 5% of Rac2 were activated after 5 s, similar to previously reported levels [3] . In P-Rex1 −/− neutrophils, Rac1 peak activation was reduced by 25% ( Figure 2B ) and Rac2 activation by 50% ( Figure 2C ), suggesting that P-Rex1 acts through both Rac isoforms but mainly through Rac2. This is a first description of the substrate specificity of endogenous P-Rex1 and of a GEF being able to distinguish between Rac isoforms.
We measured the fMLP-dependent activation of two known neutrophil Rac targets, p38 MAPK and p42/p44 Erk [6, 7] , as well as of the PI3K target PKB [11] [12] [13] ( Figure S2 ). They were unaffected by the P-Rex1 deficiency, suggesting that partial Rac activation is suffi- cient to stimulate these signaling pathways in neutrophils.
It is worthwhile discussing that P-Rex1 activates Rac2 preferentially over Rac1, because these play distinct roles in neutrophils. In humans, Rac2 is the predominant neutrophil isoform, whereas in mice, Rac2 and Rac1 are expressed equally [3] . Rac2-deficiency in humans (D57N mutation) causes severe recurrent bacterial infections, with neutrophils largely unable to chemotax to sites of infection, produce ROS, or secrete granule proteins [ 
ROS Formation in Neutrophils from P-Rex1
−/− Mice We tested GPCR-dependent ROS production. In unprimed fMLP-or C5a-stimulated P-Rex1 +/+ neutrophils, ROS formation was low, but it was even lower in P-Rex1 −/− cells (up to 30%), and with slightly delayed onset ( Figures 3A and 3B ). Priming of P-Rex1 +/+ cells with LPS or TNFα prior to fMLP or C5a stimulation resulted in a 6-8-fold increase in ROS production ( Figures  3C-3E ). The LPS-primed fMLP-or C5a-stimulated response was almost completely absent in P-Rex1 −/− neutrophils, i.e., roughly at unprimed levels ( Figures 3C  and 3D ), whereas the TNFα-primed response was only reduced by 30% ( Figure 3E , and data not shown). Hence, P-Rex1 regulates GPCR-dependent ROS formation both in unprimed and primed neutrophils, but its biggest impact is on LPS-primed GPCR-dependent ROS formation.
The finding that P-Rex1 regulates ROS formation corroborates data obtained previously through antisense treatment of NB4 and HL60 cells [14] and is consistent with the notion that P-Rex1 preferentially activates Rac2 over Rac1. The fact that P-Rex1 distinguishes between LPS and TNFα priming suggests that the LPSpriming pathway specifically, rather than a primed state in general, depends on P-Rex1. LPS signals through TLR4 via various adaptor proteins, IRAKs, Btk, and members of the MAPK family [17] . We do not know whether any of these LPS-signaling mediators are involved in regulating P-Rex1. We tested ROS formation in P-Rex1 −/− neutrophils stimulated via GPCR-independent pathways. IgG-opsonized zymosan, which engages mainly FcγRIIa, induced normal ROS formation ( Figure 3F ), implying that P-Rex1 plays little role in FcR-mediated signaling. ROS formation was also normal in PMA-stimulated cells, suggesting that P-Rex1 is not involved in protein kinase C-dependent activation of the NADPH oxidase ( Figure 3G ).
Chemotaxis of Neutrophils from P-Rex1
−/− Mice P-Rex1 has often been proposed to link GPCRs and PI3Kγ to Rac in neutrophil chemotaxis, without there being experimental evidence. We measured chemotaxis of P-Rex1 −/− neutrophils in transwell and Dunn chamber assays [3, 5, 6, 10]. In the transwell assay, fMLP-or C5a-induced chemotaxis was surprisingly little affected by the P-Rex1-deficiency: fMLP-stimulated migration was variable but on average normal, and C5a-dependent migration was reduced by 30% ( Figure  4A Figure 4D and Figure S3C) . Similarly, fMLP-or C5a-induced actin polymerization was slightly reduced over a range of doses at 10 and 30 s, but again the defect was small ( Figure 4E and Figure S3D ). Hence, although P-Rex1-deficiency causes a defect in neutrophil motility, it is surprisingly mild, suggesting that P-Rex1 is not an essential regulator of neutrophil chemotaxis.
Interestingly, a recent report has shown that P-Rex1 is expressed in brain as well as neutrophils, and P-Rex1-RNAi treatment of PC12 cells results in a striking defect in NGF-induced motility [18] . Hence, intriguingly, in neuronal cells that move slowly and only during development in vivo, the role of P-Rex1 in chemotaxis seems greater than in "professionally" chemotaxing neutrophils.
Recruitment of P-Rex1
−/− Neutrophils to Sites of Inflammation Neutrophil recruitment to sites of infection is crucial for host defense against bacteria and fungi. This involves neutrophil chemotaxis but also their ability to leave the blood stream and reach the infected site. We measured neutrophil recruitment to sites of inflammation in P-Rex1 −/− animals in an aseptic-peritonitis model [6, 11] , with thioglycollate as the inflammatory agent. Leukocytes present in the peritoneum of untreated animals were mainly macrophages but no neutrophils ( Figure  4F ). Thioglycollate elicited a robust recruitment of neutrophils to the peritoneum of P-Rex1 +/+ animals within 4-5 hr. This was reduced by 50% in P-Rex1 −/− animals ( Figure 4F ). Hence, P-Rex1 controls neutrophil recruitment to sites of inflammation in intact animals.
Degranulation of Azurophil Granules from Neutrophils of P-Rex1
−/− Mice An important Rac2-dependent neutrophil response is degranulation of azurophil myeloperoxidase (MPO)-containing granules [4, 8] . We measured MPO secretion in cytochalasin B-pretreated fMLP-stimulated neutrophils. It was unaffected by the P-Rex1-deficiency (Figure S4) . The amount of MPO was equal in P-Rex1 −/− and P-Rex1 +/+ cells (data not shown), and the level of degranulation was comparable to previous reports (fMLP-stimulated MPO secretion in Figure S4 corresponds to 35%) [8] . Without finding a defect, we measured fMLP-and C5a-stimulated degranulation with or without cytochalasin B pretreatment and LPS or TNFα priming, over timeframes of 30 s to 90 min and over wide dose ranges, or upon Ig-opsonized zymosanstimulation (data not shown). Hence, P-Rex1 does not regulate Rac2 pathways leading to azurophil granule release.
The Role of P-Rex1 in Neutrophil Responses
This paper shows that P-Rex1 regulates Rac2 activation and ROS formation in neutrophils stimulated via GPCRs, as well as neutrophil recruitment to inflammatory sites. It also demonstrates a surprising role for P-Rex1 in LPS priming of GPCR-dependent ROS formation. Together, our results suggest that P-Rex1 is an 
